Computational drug discovery for the Zika virus

In this paper the OpenZika team summarize current computational drug discovery efforts and their applicability to discovery of anti-ZIKV drugs. Lastly,  successful examples of the use of computational approaches to ZIKV drug discovery are presented.


Learn more


Zika Might Cause Brain Damage In Adults, Too

Although most risk associated with Zika so far has focused on infants, it turns out that adults might not be in the clear.

Researchers from Rockefeller University and the La Jolla Institute for Allergy and Immunology say there’s evidence that Zika could inflict our brain’s stem cells, even as adults.

Figure thumbnail fx1

Read more

Although ZIKV is considered a transient infection in adult humans without marked long-term effects, there may in fact be consequences of exposure in the adult brain.

Read the original paper published in the journal Cell Stem Cell


Outbreak of Zika in India, 2018

India has recorded its biggest outbreak of Zika virus to date (October 12th), with 32 cases confirmed in Jaipur, capital of the western state of Rajasthan.

The number of suspected cases cannot be estimated, said Veenu Gupta, the Additional Chief Secretary of the Medical and Health & Family Welfare Department for the state, adding that samples are being collected daily from all residents in a three kilometer radius. “Those who test positive are reported.”

This is India’s third outbreak since 2017.

Zika Virus Infection Fast Facts

Read more


The A-Z of Zika drug discovery

A comprehensive A-Z review of the recent advances in ZIKV drug discovery efforts is presented, highlighting drug repositioning and computationally guided compounds, including discovered viral and host cell inhibitors. Promising ZIKV molecular targets are also described and discussed, as well as targets belonging to the host cell, as new opportunities for ZIKV drug discovery. All this knowledge is not only crucial to advancing the fight against the Zika virus and other flaviviruses but also helps us prepare for the next emerging virus outbreak to which we will have to respond.

Figure 1

Learn more


A single mutation in the prM protein of Zika virus contributes to fetal microcephaly

Phylogenetic analysis reveals that contemporary epidemic strains have accumulated multiple substitutions from their Asian ancestor. Here, we show that a single serine to asparagine substitution (S139N) in the viral polyprotein substantially increased ZIKV infectivity in both human and mouse neural progenitor cells (NPCs), led to more significant microcephaly in the mouse fetus, and higher mortality in neonatal mice. Evolutionary analysis indicates that the S139N substitution arose before the 2013 outbreak in French Polynesia and has been stably maintained during subsequent spread to the Americas. This functional adaption makes ZIKV more virulent to human NPCs, thus contributing to the increased incidence of microcephaly in recent ZIKV epidemics.

Read more


Zika virus replication in the mosquito Culex quinquefasciatus in Brazil

Zika virus (ZIKV) is a flavivirus that has recently been associated with an increased incidence of neonatal microcephaly and other neurological disorders. The virus is primarily transmitted by mosquito bite, although other routes of infection have been implicated in some cases. The Aedes aegypti mosquito is considered to be the main vector to humans worldwide; however, there is evidence that other mosquito species, including Culex quinquefasciatus, transmit the virus. To test the potential of Cx. quinquefasciatus to transmit ZIKV, we experimentally compared the vector competence of laboratory-reared Ae. aegypti and Cx. quinquefasciatus. Interestingly, we were able to detect the presence of ZIKV in the midgut, salivary glands and saliva of artificially fed Cx. quinquefasciatus. In addition, we collected ZIKV-infected Cx. quinquefasciatus from urban areas with high microcephaly incidence in Recife, Brazil. Corroborating our experimental data from artificially fed mosquitoes, ZIKV was isolated from field-caught Cx. quinquefasciatus, and its genome was partially sequenced. Collectively, these findings indicate that there may be a wider range of ZIKV vectors than anticipated.

Genoma vírus Zika


UFG descobre novos compostos que podem ajudar a tratar pessoas com zika

A Universidade Federal de Goiás (UFG) descobriu novos compostos que podem ajudar no tratamento de pessoas com o vírus da zika. Ao todo, nove substâncias foram selecionadas para testes em células infectadas, que serão feitos em uma universidade dos Estados Unidos. O objetivo é desenvolver medicamentos para combater a doença.


Leia mais


UFG descobre novos possíveis compostos contra o vírus Zika

Em maio de 2016, a Universidade Federal de Goiás (UFG), em parceria com a World Community Grid (WCG), da International Business Machines (IBM), iniciou o projeto OpenZika, que visa identificar substâncias com potencial para tratar pessoas infectadas pelo vírus Zika. De uma lista inicial de aproximadamente 7.600 compostos, dentre eles fármacos já aprovados para uso em humanos, cinco foram selecionados e estão em fases de testes in vitro na University of California San Diego  (UCSD). Agora, o grupo acaba de descobrir mais nove substâncias potenciais que serão testadas.

A descoberta surgiu em uma segunda leva de pesquisas com 260 compostos adicionais que foram testados por meio de uma triagem virtual, maior e mais diversa, contra as estruturas cristalinas da proteína helicase NS3 do vírus Zika, ligadas ao ácido ribonucleico (RNA). Os compostos também serão encaminhados para a universidade californiana ainda neste mês de março, na busca do desenvolvimento de um medicamento antiviral.

Open Zika

Leia mais